Literature DB >> 10727399

Physical characterization of the MUC5AC mucin: a highly oligomeric glycoprotein whether isolated from cell culture or in vivo from respiratory mucous secretions.

J K Sheehan1, C Brazeau, S Kutay, H Pigeon, S Kirkham, M Howard, D J Thornton.   

Abstract

We have isolated the high-M(r) mucins from growth medium of the early stage of an HT-29 cell culture by gel chromatography and isopycnic density gradient centrifugation. The mucins (buoyant density 1.34-1.44 g/ml) were reactive with an anti-peptide antiserum (MAN-5ACI) raised against a sequence from within the MUC5AC mucin. Similar antisera raised against the MUC2 and MUC5B mucins were not reactive. The MUC5AC reduced-mucin subunits exhibited a homogeneous charge distribution on anion-exchange chromatography, but appeared as two bands, one major and one more minor, after agarose gel electrophoresis. The unreduced mucins had an average M(r) in excess of 40 MDa and were visualized in the electron microscope as large, fine filamentous threads (many microns in length) that after reduction were greatly reduced in size (number average length 570 nm). Agarose gel electrophoresis of unreduced MUC5AC mucins identified a major band just entering the gel with evidence of a 'ladder' of faster-migrating minor bands. Partial reduction of the mucins increased the proportion of the faster bands and at least 16 could be discriminated. M(r) measurements showed that these bands differed by single monomer units. The mucins behaved as very stiff extended structures in solution and this characteristic might explain the poor separation of different-sized oligomers in sedimentation-rate experiments. The cell-culture mucin preparation had similar characteristics of charge and buoyant density to MUC5AC mucins from respiratory secretions in vivo. In addition the MUC5AC mucin from respiratory tract secretions exhibited similar behaviour, reduced and unreduced on agarose gel electrophoresis, indicating that the mucin has a similar molecular phenotype in vivo and in vitro.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10727399      PMCID: PMC1220928     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Genomic organization of the human mucin gene MUC5B. cDNA and genomic sequences upstream of the large central exon.

Authors:  J L Desseyn; M P Buisine; N Porchet; J P Aubert; A Laine
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

2.  Peptides of human bronchial mucus glycoproteins. Size determination by electron microscopy and by biosynthetic experiments.

Authors:  T Marianne; J M Perini; J J Lafitte; N Houdret; F R Pruvot; G Lamblin; H S Slayter; P Roussel
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

3.  Electron microscopy of cervical, gastric and bronchial mucus glycoproteins.

Authors:  J K Sheehan; K Oates; I Carlstedt
Journal:  Biochem J       Date:  1986-10-01       Impact factor: 3.857

4.  Methods for separation and deglycosylation of mucin subunits.

Authors:  D J Thornton; M Howard; P L Devine; J K Sheehan
Journal:  Anal Biochem       Date:  1995-05-01       Impact factor: 3.365

5.  Quantitation of mucus glycoproteins blotted onto nitrocellulose membranes.

Authors:  D J Thornton; D F Holmes; J K Sheehan; I Carlstedt
Journal:  Anal Biochem       Date:  1989-10       Impact factor: 3.365

6.  Structural analysis of purified human tracheobronchial mucins.

Authors:  R Gupta; N Jentoft; A M Jamieson; J Blackwell
Journal:  Biopolymers       Date:  1990-02-05       Impact factor: 2.505

Review 7.  Mucin structure. The structure and heterogeneity of respiratory mucus glycoproteins.

Authors:  J K Sheehan; D J Thornton; M Somerville; I Carlstedt
Journal:  Am Rev Respir Dis       Date:  1991-09

8.  Complex structure of human bronchial mucus glycoprotein.

Authors:  H S Slayter; G Lamblin; A Le Treut; C Galabert; N Houdret; P Degand; P Roussel
Journal:  Eur J Biochem       Date:  1984-07-16

9.  Mucus glycoproteins from 'normal' human tracheobronchial secretion.

Authors:  D J Thornton; J R Davies; M Kraayenbrink; P S Richardson; J K Sheehan; I Carlstedt
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

10.  Isolation and characterization of human cervical-mucus glycoproteins.

Authors:  I Carlstedt; H Lindgren; J K Sheehan; U Ulmsten; L Wingerup
Journal:  Biochem J       Date:  1983-04-01       Impact factor: 3.857

View more
  31 in total

1.  Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucus.

Authors:  Ute Schwab; Lubna H Abdullah; Olivia S Perlmutt; Daniel Albert; C William Davis; Roland R Arnold; James R Yankaskas; Peter Gilligan; Heiner Neubauer; Scott H Randell; Richard C Boucher
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

Review 2.  The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 3.  Airway mucus: From production to secretion.

Authors:  Olatunji W Williams; Amir Sharafkhaneh; Victor Kim; Burton F Dickey; Christopher M Evans
Journal:  Am J Respir Cell Mol Biol       Date:  2006-01-13       Impact factor: 6.914

4.  Coordinated release of nucleotides and mucin from human airway epithelial Calu-3 cells.

Authors:  Silvia M Kreda; Seiko F Okada; Catharina A van Heusden; Wanda O'Neal; Sherif Gabriel; Lubna Abdullah; C William Davis; Richard C Boucher; Eduardo R Lazarowski
Journal:  J Physiol       Date:  2007-07-26       Impact factor: 5.182

5.  Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B.

Authors:  Sara Kirkham; John K Sheehan; David Knight; Paul S Richardson; David J Thornton
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

6.  Cleavage in the GDPH sequence of the C-terminal cysteine-rich part of the human MUC5AC mucin.

Authors:  Martin E Lidell; Gunnar C Hansson
Journal:  Biochem J       Date:  2006-10-01       Impact factor: 3.857

Review 7.  Current status of mucins in the diagnosis and therapy of cancer.

Authors:  Satyanarayana Rachagani; Maria P Torres; Nicolas Moniaux; Surinder K Batra
Journal:  Biofactors       Date:  2009 Nov-Dec       Impact factor: 6.113

8.  Heterogeneity and persistence length in human ocular mucins.

Authors:  A N Round; M Berry; T J McMaster; S Stoll; D Gowers; A P Corfield; M J Miles
Journal:  Biophys J       Date:  2002-09       Impact factor: 4.033

9.  Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins.

Authors:  Kathryn A Ramsey; Zachary L Rushton; Camille Ehre
Journal:  J Vis Exp       Date:  2016-06-14       Impact factor: 1.355

10.  Virulent Shigella flexneri affects secretion, expression, and glycosylation of gel-forming mucins in mucus-producing cells.

Authors:  Brice Sperandio; Natalie Fischer; Marie Joncquel Chevalier-Curt; Yannick Rossez; Pascal Roux; Catherine Robbe Masselot; Philippe J Sansonetti
Journal:  Infect Immun       Date:  2013-07-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.